Precisión numérica y clínica de la monitorización continua de glucosa en pacientes colombianos en terapia con bomba de infusión de insulina con suspensión automática en hipoglucemia

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Modern-day clinical course of type 1 diabetes mellitus after 30 years of duration. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005). Arch Intern Med. 2009; 169 (14): 1307-1316. Aschner, 2010, Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management, Int J Clin Pract, 64, 305, 10.1111/j.1742-1241.2009.02296.x 1995, Adverse events and their association with treatment regimens in the diabetes control and complications trial, Diabetes Care, 18, 1415, 10.2337/diacare.18.11.1415 Nathan, 2005, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, New England Journal of Medicine, 353, 2643, 10.1056/NEJMoa052187 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Thompson, 1996, How have patients reacted to the implications of the DCCT, Diabetes Care, 19, 876, 10.2337/diacare.19.8.876 McCrimmon, 2010, Hypoglycemia in type 1 diabetes, Diabetes., 59, 2333, 10.2337/db10-0103 Garg, 2006, Improvement in glycemic excursions with a transcutaneous, real-time continous glucose sensor: A randomized controlled trial, Diabetes Care, 29, 44, 10.2337/diacare.29.01.06.dc05-1686 Monsod, 2002, Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia, Diabetes Care, 25, 889, 10.2337/diacare.25.5.889 Garg, 2004, Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes, Diabetes Care, 27, 734, 10.2337/diacare.27.3.734 Kulcu, 2003, Physiological differences between interstitial glucose and blood glucose measured in human subjects, Diabetes Care, 26, 2405, 10.2337/diacare.26.8.2405 Keenan, 2010, Accuracy of a new real-time continous glucose monitoring algorithm, J Diabetes Sci Technol, 4, 111, 10.1177/193229681000400114 2004, Accuracy of the GlucoWatch G2 biographer and the continuous glucose monitoring system during hypoglycemia: experience of the diabetes research in children network, Diabetes care, 27, 722, 10.2337/diacare.27.3.722 Clarke, 2009, Statistical tools to analyze continous glucose monitor data, Diabetes Technol Ther, 11, S45, 10.1089/dia.2008.0138 Kropff, 2015, Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions, Diabetes Obes Metab., 17, 343, 10.1111/dom.12378 2006, Evaluation of factors affecting CGMS calibration, Diabetes Technol Ther, 5, 318 Rebrin, 1999, Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring, Am J Physiol Endocrinol Metab, 277, E561, 10.1152/ajpendo.1999.277.3.E561 Hirsch, 2008, Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for Continuous Glucose Monitoring (CGM), Diabetes Technol Ther, 10, 232, 10.1089/dia.2008.0016 Penformis, 2011, Evolution of devices in diabetes management, Diabetes Technol Ther, 13, S93, 10.1089/dia.2011.0058 Klonoff, 2011, Continuous glucose monitoring: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 96, 2968, 10.1210/jc.2010-2756 Tamborlane, 2008, Continous glucose monitoring and intensive treatment of type 1 diabetes, N Engl J Med., 359, 1464, 10.1056/NEJMoa0805017 Bergenstal, 2010, Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes (STAR 3 Trial), N Engl J Med., 363, 311, 10.1056/NEJMoa1002853 Kordonouri, 2010, Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment, Diabetologia., 53, 2487, 10.1007/s00125-010-1878-6 Hirsch, 2008, Sensor-augmented insulin pump therapy: results from the first randomized treat-to-target study, Diabetes Technol Ther., 10, 377, 10.1089/dia.2008.0068 Kollman, 2005, Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors, Diabetes Technol Ther., 7, 665, 10.1089/dia.2005.7.665